Picton Mahoney Asset Management’s Quantum FinTech Acquisition Corporation Warrants, each warrant exercisable for one-half of one share of Common Stock at an exercise price of $11.50 QFTA.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding QFTA.WS
RCM
MI
HCM
LA
CH
BFM
OCAM
Picton Mahoney Asset Management's QFTA.WS Position: Q4 2021 in Review
Picton Mahoney Asset Management sold out of Quantum FinTech Acquisition Corporation Warrants, each warrant exercisable for one-half of one share of Common Stock at an exercise price of $11.50 (QFTA.WS) in Q4 2021, closing a stake of 250,000 shares — an estimated $68K sold.
Picton Mahoney Asset Management first reported a position in QFTA.WS in Q3 2021 and held it in 1 quarter. The position peaked at $68K in Q3 2021. 38 funds tracked by Wall St. Rank hold QFTA.WS as of Q4 2021.
- Picton Mahoney Asset Management reported no remaining Quantum FinTech Acquisition Corporation Warrants, each warrant exercisable for one-half of one share of Common Stock at an exercise price of $11.50 position as of Q4 2021 after selling out during the quarter.
- Picton Mahoney Asset Management sold 250,000 Quantum FinTech Acquisition Corporation Warrants, each warrant exercisable for one-half of one share of Common Stock at an exercise price of $11.50 shares in Q4 2021, an estimated $68K.
- Picton Mahoney Asset Management first reported a position in Quantum FinTech Acquisition Corporation Warrants, each warrant exercisable for one-half of one share of Common Stock at an exercise price of $11.50 in Q3 2021 and held it in 1 quarter.
- Picton Mahoney Asset Management's Quantum FinTech Acquisition Corporation Warrants, each warrant exercisable for one-half of one share of Common Stock at an exercise price of $11.50 position peaked at $68K in Q3 2021.
- 38 funds tracked by Wall St. Rank held Quantum FinTech Acquisition Corporation Warrants, each warrant exercisable for one-half of one share of Common Stock at an exercise price of $11.50 as of Q4 2021.
Based on Picton Mahoney Asset Management's 13F filing for Q4 2021, filed 10 Feb 2022.